Type 2 & other diabetes

Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas

DiabetologiaPublished Genetic association study with meta-analysis

Pooled resultResult — go to the resultOdds ratio 3.9 95% CI 1.4–12

Authors' conclusion

Rare P/LP GLIS3 variants do contribute to type 2 diabetes risk. The variants located in the distal part of the protein could have a direct effect on its functional activity by impacting its transactivation domain, by homology with the mouse GLIS3 protein. Furthermore, rare P/LP GLIS3 variants seem to have a direct clinical effect on beta cell function, which could be improved by increasing insulin secretion via the use of sulfonylureas.

Study context

Population
Individuals from the RaDiO study; replication in the 52K study (43,125 individuals) and TOPMed study (44,083 individuals)RaDiO
Participants
5,471 individuals
Comparison
Carriers of rare P/LP GLIS3 variants vs non-carriers
Outcome
Association between rare P/LP GLIS3 variants and T2D risk
Methodological detailstargeted resequencing, ACMG variant classification, luciferase functional assays, meta-analysis of RaDiO, 52K and TOPMed
  • Targeted resequencing
  • ACMG variant classification
  • Luciferase functional assays
  • Meta-analysis of RaDiO, 52K and TOPMed

Pooled result

As reported in the abstract

Odds ratio

3.9

95% CI 1.4–12

P = 3.0×10-3

P/LP carriersvs Non-carriers
OR 3.9 (95% CI 1.4–12); P = 3.0×10-3

Further pooled results

Meta-analysis (RaDiO, 52K, TOPMed): enrichment of P/LP GLIS3 variants in individuals with T2D

OR
2.1 (95% CI 1.4, 2.9)
P value
P = 5.6×10-5
  • 7 P/LP variants identified in both 52K and TOPMed

Clinical traits in carriers vs non-carriers with T2D

Adiposity, age at T2D diagnosis and cholesterol similar between variant carriers and non-carriers with T2D

Sulfonylurea sensitivity in carriers with T2D

All carriers with T2D were sensitive to oral sulfonylureas

Location of P/LP variants: last two exons vs remaining exons

Enrichment in last two exons, OR
OR>3.5
P value
P < 5×10-6
  • 18 rare variants classified as P/LP

Original publication

Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas. Diabetologia. Published 5 December 2023. doi:10.1007/s00125-023-06035-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.